Mural Oncology plc (NASDAQ:MURA)’s traded shares stood at 0.34 million during the last session, with the company’s beta value hitting 3.72. At the close of trading, the stock’s price was $4.00, to imply an increase of 8.40% or $0.31 in intraday trading. The MURA share’s 52-week high remains $5.62, putting it -40.5% down since that peak but still an impressive 28.25% since price per share fell to its 52-week low of $2.87. The company has a valuation of $68.24M, with an average of 0.27 million shares in intraday trading volume over the past 10 days and average of 183.58K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Mural Oncology plc (MURA), translating to a mean rating of 1.00. Of 2 analyst(s) looking at the stock, 0 analyst(s) give MURA a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 2 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -1.98.
Mural Oncology plc (NASDAQ:MURA) trade information
After registering a 8.40% upside in the last session, Mural Oncology plc (MURA) has traded red over the past five days. The 5-day price performance for the stock is 2.83%, and 16.28% over 30 days. With these gigs, the year-to-date price performance is 24.22%. Short interest in Mural Oncology plc (NASDAQ:MURA) saw shorts transact 0.41 million shares and set a 3.85 days time to cover.
Mural Oncology plc (MURA) estimates and forecasts
Looking at statistics comparing Mural Oncology plc share performance against respective industry, we note that the company has outperformed competitors. Mural Oncology plc (MURA) shares are 16.96% up over the last 6 months, with its year-to-date growth rate higher than industry average at 39.34% against 16.60%.
MURA Dividends
Mural Oncology plc has its next earnings report out in February. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
We also have Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Mural Oncology plc (MURA) shares. Going by data provided on Sep 30, 2024 , Vanguard Total Stock Market Index Fund holds roughly 520.28 shares. This is just over 3.06% of the total shares, with a market valuation of $2.08 million. Data from the same date shows that the other fund manager holds a little less at 236.78, or 1.39% of the shares, all valued at about 0.95 million.
